printlogo
http://www.ethz.ch/index_EN
Welcome to the Functional Materials Laboratory!
 
print
  

Purification of Complex Liquids

What's new?

News and events

Motivated "Hilfsassistenten" (research) wanted...

Contact us!

ICB meets ICB!
flyer_may

New Spin-off!

smartodont_web_copyright



Order online

Nanoparticle_dispersions

Magnetic Chemistry

makechemmagn
tblogo

Order online: www.turbobeads.com


The Functional Materials Laboratory FML  is operating at ETH Zurich within the Department of Chemistry and Applied Biosciences D-CHAB and the Institute for Chemical and Bioengineering ICB

Wastewater purification

Carbon coated magnetic metallic nanoparticles are well suited to treat industrial wastewater. Their carbon coating gives them a high stability under a wide range of different conditions (pH, temperature) and allows the covalent binding of highly specific chelating agents. In our laboratory, we use these newly produced magnetic chelators to purify water from a targeted atoms or molecules. The extremely highly magnetic saturation of these magnetic chelators enhances the efficiency of their collection in a high gradient magnetic filter and thus permits the treatment of large volumes in a short period of time. The magnetic chelators have already proven their ability to remove specifically heavy metal or noble metal in a lab scale pilot plan. We are currently building a continuous magnetic wastewater treatment set-up to further optimize this separation method.

Story_Metal
Blood purification

We investigate the direct injection of stable carbon coated metal nanomagnets into whole blood for the efficient, magnetic extraction-based extracorporeal removal of low and high molecular compounds. We demonstrated the successful extraction of metal ions (Pb2+), steroid drugs (digoxin, cardiac drug) and proteins (interleukin-6 (IL-6), inflammatory mediator) whilst monitoring blood integrity using a series of clinically important parameters. Combined with existing therapies, these results may have major implications for the treatment of severe intoxications (digoxin, barbiturates), sepsis (specific filtering of (multiple) cytokines or toxins), metabolic disorders (thyreotoxicosis, hyperfibrinogenemia and hyperlipoproteinemia) and auto-immune diseases (removal of pathogenic auto-antibodies or immune-complexes).

purification


We are currently developing an extracorporeal blood purification device to exploit the efficiency of nanoparticle-based blood purification in an ex vivo setup.


Further reading:

 

Wichtiger Hinweis:
Diese Website wird in älteren Versionen von Netscape ohne graphische Elemente dargestellt. Die Funktionalität der Website ist aber trotzdem gewährleistet. Wenn Sie diese Website regelmässig benutzen, empfehlen wir Ihnen, auf Ihrem Computer einen aktuellen Browser zu installieren. Weitere Informationen finden Sie auf
folgender Seite.

Important Note:
The content in this site is accessible to any browser or Internet device, however, some graphics will display correctly only in the newer versions of Netscape. To get the most out of our site we suggest you upgrade to a newer browser.
More information

© 2012 ETH Zurich | Imprint | Disclaimer | 4 November 2011
top